Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Automatic Content Recognition Market Size Rhamnolipids Market Size Odor Control System Market Size Product Engineering Services MarketGlobal Small Animal Imaging (In-vivo) Market Size To Exceed USD 2.41 Billion By 2033
According to a research report published by Spherical Insights & Consulting, The Global Small Animal Imaging (In-vivo) Market Size is Expected to Grow from USD 1.16 Billion in 2023 to USD 2.41 Billion by 2033, at a CAGR of 7.59% during the forecast period 2023-2033.
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On The Global Small Animal Imaging (In-vivo) Market Size, Share, and COVID-19 Impact Analysis, By Modality (Optical Imaging Systems, Micro-Magnetic Resonance Imaging and Nuclear Imaging), By Application (Monitoring Drug Treatment Response, Biodistribution Studies, Cancer, Cell Detection, Biomarkers, Longitudinal Studies, and Epigenetics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
The worldwide need for products and services that allow for the non-invasive observation and measurement of biological processes in living small animals, mainly mice and rats, is included in the Small Animal Imaging (In-vivo) Market. This market covers a range of imaging modalities that are essential for preclinical research, basic research, and drug discovery, including optical, nuclear, and micro-MRI imaging. The non-invasive observation, measurement, and examination of both healthy and unhealthy processes in living animal organs and tissues is known as small animal imaging (in vivo). Seeing biological processes within a living body using a variety of imaging modalities offers insights into the course of disease, the effectiveness of treatment, and other physiological phenomena. Furthermore, the need for expensive equipment for clinical research has grown as a result of the expansion of the pharmaceutical and clinical research industries. This has raised the need for real-time data storage solutions, in vivo imaging equipment, and high-resolution modalities. The number of treatments and preclinical research approved by regulatory bodies has increased. However, cost, ethical issues, technical difficulties, and access to specialist technology like PET tracers are some of the issues facing the small animal imaging (in vivo) sector.
The optical imaging systems segment dominated the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the modality, the global small animal imaging (in-vivo) market is divided into optical imaging systems, micro-magnetic resonance imaging, and nuclear imaging. Among these, the optical imaging systems segment dominated the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The rising need for precise and noninvasive optical imaging techniques needed for preclinical research was the reason for this expansion. Since the method employed in optical imaging systems is usually noninvasive or minimally invasive, it is possible to conduct recurrent imaging tests to monitor the course of the disease and the effectiveness of treatment. The animal bodies will experience less stress as a result.
The biodistribution studies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the application, the global small animal imaging (in-vivo) market is divided into monitoring drug treatment response, biodistribution studies, cancer, cell detection, biomarkers, longitudinal studies, and epigenetics. Among these, the biodistribution studies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. Small animal imaging combined with biodistribution studies provides the information required to understand how drugs interact with the body. Biodistribution is used to study drug movement, as well as its absorption, distribution, and excretion. Increasing the specificity of small animal imaging techniques is helping to improve the accuracy of biodistribution investigations.
Asia Pacific is anticipated to hold the highest share of the global small animal imaging (in-vivo) market over the projected period.
Asia Pacific is anticipated to hold the highest share of the global small animal imaging (in-vivo) market over the projected period. The development of the pharmaceutical and medical research industries in this area was credited with this expansion. The need for small animal imaging methods has grown as a result of significant investments made by the major market participants in the study and creation of novel medications and treatments. The need for small animal imaging devices for preclinical research has grown as a result of government funding and a supportive regulatory environment.
North America is estimated to grow at the fastest CAGR in the global small animal imaging (in-vivo) market during the forecast period. This is attributable to the rise in the healthcare industry and the region's general economic prosperity. The research industry is also expanding as a result of significant government and private investment. In addition, the need for research institutions has grown as a result of the increased occurrence of diseases like cancer. The market for small animal imaging has grown as a result of these factors.
Company Profiling
Major vendors in the global small animal imaging (in-vivo) market are Bruker Corporation, MR Solutions Ltd., Mediso Ltd., Hitachi Ltd., LI-COR Biosciences, Aspect Imaging, TriFoil Imaging, Agilent Technologies, Inc., Siemens Healthineers AG, Miltenyi Biotec, GE Healthcare, PerkinElmer, Inc., Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, and other key vendors.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global small animal imaging (in-vivo) market based on the below-mentioned segments:
Global Small Animal Imaging (In-vivo) Market, By Modality
Global Small Animal Imaging (In-vivo) Market, By Application
Global Small Animal Imaging (In-vivo) Market, By Regional
Jun 2025 - The Global Guar Market Size is Expected to Grow from USD 0.74 Billion in 2023 to USD 0.95 Billion by 2033, at a CAGR of 2.19% during the forecast period 2023-2033
Jun 2025 - The Global Peas Market Size is Expected to Grow from USD 66.87 Billion in 2023 to USD 83.01 Billion by 2033, at a CAGR of 2.19% during the forecast period 2023-2033
Jun 2025 - The Global Pet Bird Health Market Size is Expected to Grow from USD 880.7 Million in 2023 to USD 1958.2 Million by 2033, at a CAGR of 8.32% during the forecast period 2023-2033
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
